US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist

14.145
+0.035+0.25%

Trading Nov 27 10:45 ET

1.29BMarket Cap-5181P/E (TTM)

Rocket Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rocket Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 34.780K	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 34.780K--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Rocket Pharmaceuticals Earnings Reports

10-Q: Q3 2024 Earnings Report

Nov 7 16:54 ET

8-K: Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

Nov 7 16:29 ET

10-Q: Q2 2024 Earnings Report

Aug 6 16:37 ET

8-K: Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress

Aug 5 16:22 ET

Analyst Rating

Updated: Nov 19, 2024

Strong Buy

Buy
92.31%
Hold
7.69%
Sell
0.00%

Price Target

No Data

Heat List

Overall